Truvada, a drug for people prone to infection, which should be taken daily for an extended period is called.
The Federal Agency for food and drugs (FDA) of the United States took a decision that could become a landmark in the history of the fight against AIDS, to approve a pill for the prevention of infection in adults with greater exposure to contagion.
Since 2004, Truvada, a combination of two drugs of the Gilead Sciences Laboratory, is indicated along with other antiretroviral drugs for the treatment of HIV-positive patients. But two years ago, several clinical trials showed that daily and regularly taking this medication can reduce a 75% infection. Yesterday, the FDA accepted the preventive provision, whenever doctors ascertain that the patient is not infected and that checks are carried out every three months. However, the announcement did not have total acceptance: several specialists warned about its limitations, and other health care providers were fearful that the news will encourage high-risk sexual behaviors in the medium term.
"It is good news, but there is to assess how to adapt it to the reality. For those more vulnerable populations, such as sex workers, this medication can be a good tool. But, we must be wary that this does not involve a relaxation of the care and precautions", explained Dr. Carlos Falistocco, head of the National Directorate of AIDS, dependent on the Ministry of health to Tiempo Argentino. Asked about the possibility that the use of this medication be incorporated into policies of prevention of this portfolio in the Argentina, Falistocco explained: "the State would have to think about it much, because we have enough prevention mechanisms for access to these populations with delivery of condoms and other health policies. To reach that should burn before other stages and work much more on these vulnerable populations."
Apart from the scientific debate, social organizations linked to the topic raised concerns about the relevance of the announcement. Patricia Pérez, President of the ICW, suspicious of the news due to its proximity to the World AIDS Conference which begins this July 19 in Washington and said that, since the social and political point of view, the novelty is dangerous. "United Nations insists reach 0 infections. But if countries are reducing their budgets in health and if there are countries, such as Honduras, which supplied expired medicines, should be suspected of the feasibility of that goal. "Hopefully serve, but we must see it in operation", said.